SLC2A13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.15459888714054E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.52920026536196E-10 |
Normal-vs-Stage2 |
1.68278000000077E-05 |
Normal-vs-Stage3 |
8.64130988986744E-12 |
Normal-vs-Stage4 |
2.74225087082414E-13 |
Stage1-vs-Stage2 |
4.349000E-01 |
Stage1-vs-Stage3 |
4.496500E-02 |
Stage1-vs-Stage4 |
3.628600E-04 |
Stage2-vs-Stage3 |
8.534300E-02 |
Stage2-vs-Stage4 |
1.972320E-02 |
Stage3-vs-Stage4 |
2.537400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.61249918867657E-11 |
Normal-vs-AfricanAmerican |
1.59939950172827E-10 |
Normal-vs-Asian |
1.172350E-02 |
Caucasian-vs-AfricanAmerican |
5.786000E-01 |
Caucasian-vs-Asian |
8.639600E-02 |
AfricanAmerican-vs-Asian |
4.732000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.24760260087487E-11 |
Normal-vs-Female |
2.58320032031634E-11 |
Male-vs-Female |
4.931400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.15527595770482E-12 |
Normal-vs-Age(41-60Yrs) |
2.22949991801613E-10 |
Normal-vs-Age(61-80Yrs) |
3.07509573360676E-11 |
Normal-vs-Age(81-100Yrs) |
2.15719999974162E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.759600E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.104000E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.068500E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.380200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.230200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.246200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.515100004987E-08 |
Normal-vs-Grade 2 |
1.32239996730732E-09 |
Normal-vs-Grade 3 |
4.63009630635725E-11 |
Normal-vs-Grade 4 |
7.58282325818982E-14 |
Grade 1-vs-Grade 2 |
4.095800E-01 |
Grade 1-vs-Grade 3 |
9.424600E-01 |
Grade 1-vs-Grade 4 |
1.401390E-01 |
Grade 2-vs-Grade 3 |
1.787230E-01 |
Grade 2-vs-Grade 4 |
9.71490000000186E-05 |
Grade 3-vs-Grade 4 |
2.076200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.53919996140439E-09 |
Normal-vs-ccB subtype |
7.40290051481907E-11 |
ccA subtype-vs-ccB subtype |
1.032450E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.28050015035797E-10 |
Normal-vs-N1 |
3.38200023541901E-10 |
N0-vs-N1 |
9.396300E-02 |
|
|